ARCHIVES

Legal experts say too many conflicts involved. HHS gave von Eschenbach a waiver for his role in C-Change.

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

Xgeva Significantly Increases Bone Metastasis-Free Survival

May 27, 2011

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

October 17, 2014

DCT Board Okays 11 Concept Contract Recompetitions

October 26, 1984

ABMT Trials Unlikely To show Clean Benefit for Breast Cancer; Data Release Debated

March 12, 1999

Conferees Agree On Extension Of Biomedical Research Authorities For Two Years; Kennedy-Waxman Bills Are Dead

November 28, 1980

Advocacy Group Tells Chicago Tribune That AIDS, Not Gallo, Is Issue

September 21, 1990